Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
Open Access
- 1 August 2016
- journal article
- research article
- Published by Elsevier in The Lancet Global Health
- Vol. 4 (8) , e534-e547
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Polio Vaccination: Past, Present and FutureFuture Microbiology, 2015
- Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in CubaVaccine, 2015
- Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysisThe Journal of Infectious Diseases, 2014
- Priming after a Fractional Dose of Inactivated Poliovirus VaccineNew England Journal of Medicine, 2013
- Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6–9 months in Moradabad, India: a community-based, randomised controlled trialThe Lancet Infectious Diseases, 2012
- Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the PhilippinesInternational Journal of Infectious Diseases, 2012
- Fractional Doses of Inactivated Poliovirus Vaccine in OmanNew England Journal of Medicine, 2010
- Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle‐Free Device in CubaThe Journal of Infectious Diseases, 2010
- Trial of a Supplemental Dose of Four Poliovirus VaccinesNew England Journal of Medicine, 2000
- Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccineThe Lancet, 1993